therapeutic vaccine

A vaccine—e.g., Salk’s Remune™—which is intended to treat a viral infection by stimulating the immune system

therapeutic vaccine

Immunology A vaccine–eg, Salk's Remune intended to treat a viral infection by stimulating the immune system. See Vaccine therapy.
Mentioned in ?
References in periodicals archive ?
The contract covers the development, manufacture, and marketing of a peptide therapeutic vaccine for the treatment of pancreatic cancer.
Theravectys, a France-based biotechnology company, has received approval to start a phase I/II clinical trial of its anti-HIV therapeutic vaccine from France's National Security Agency and Belgium's Federal Agency for Medicines and Health Products, it was reported yesterday.
Glaxo is now conducting late-stage trials of a therapeutic vaccine that would be given to cancer patients after their tumors are surgically removed, he said.
Still, although some clinical trials have demonstrated significant improvements in selected small populations, no therapeutic vaccine has yet to receive regulatory approval in the United States.
I think this and some other rationally designed therapeutic vaccine trials will offer alternative or additional therapeutic approaches.
Therapeutic vaccine testing can quickly screen many ideas, allowing for successive improvements in basic science and in products alike, greatly advancing the search for a preventive vaccine.
Stressgen Biotechnologies Corporation and Roche have formed a major global collaboration for the marketing and development of the first therapeutic vaccine for human papillomavirus (HPV) - a promising breakthrough approach to treating this serious and chronic disease.
The new, therapeutic vaccine reduces the frequency with which genital sores appear in patients infected with the herpesvirus.
OSLO, Norway -- Therapeutic vaccine company Vaccibody today announced that it has received a Euros 2 million grant from the Norwegian Research Council's BIA Program to develop a novel therapeutic vaccine against precancerous lesions of the cervix.
M2 PHARMA-April 13, 2012-Advaxis Inc's ADXS-HPV wins Best Therapeutic Vaccine at the fifth Annual Vaccine Industry Excellence Awards(C)2012 M2 COMMUNICATIONS
If such an immune response is ineffective, so would a less vigorous response induced by a heterologous therapeutic vaccine.
Further, we have developed two additional therapeutic programs based on telomerase now in animal studies -- the oncolytic virus and the therapeutic vaccine.